Leaders say FDA must focus more on public health

05/26/2009 | Wall Street Journal, The

The FDA should work to modify its reputation from that of an organization that merely approves drugs or inspects production facilities to a public-health agency focused on preventing illness, FDA Commissioner Dr. Margaret Hamburg wrote in an editorial in the New England Journal of Medicine. The article, co-authored by FDA Deputy Commissioner Dr. Joshua Sharfstein, also emphasized the need for policies to ensure safety in product approval, including conducting post-market studies of drugs and devices.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR